A vaccine that blocks infection with the human papillomavirus has helped to lower cervical cancer rates. Researchers want to ...

The incidence of Human Papillomavirus (HPV)–associated oropharyngeal cancers—tumors of the back of the mouth and throat—is ...

2 Human immunodeficiency virus (HIV) is also an immune modulating disease in consideration for its association with HS and HPV. The data indicated that HIV-positive individuals in the HPV group ...

As a result, these patients should be referred for colposcopy (Figure 3). Repeat cytology and HPV testing are indicated for risk assessment only if colposcopic findings are negative for CIN.

Those two are the most important risk factors for the development of head and neck cancer, and a patient can be HPV-positive in their tumor and a smoker at the same time, so they are not mutually ...

HPV is fuelling high cervical cancer rates in sub-Saharan Africa despite the availability of effective vaccines. Yet uptake remains l ...

Pap tests and HPV testing are a vital part of women's health care, but many people dread the invasive examination every three years. For some women, particularly sexual violence survivors ...

The incidence of Human Papillomavirus (HPV)-associated oropharyngeal cancer tumors of the back of the mouth and throat is rising. If caught early, ...